Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064 | ISIN: INE03QK01018 | Industry: Pharmaceuticals
| Expensive Performer
1031.2500 13.30 (1.31%)
NSE Jul 14, 2025 15:31 PM
Volume: 201.4K
 

announcement
Conference/Earnings Calls Alerts
1031.25
1.31%
Conference Call with Suven Pharmaceuticals Management and Analysts to discuss the acquisition of Sapala Organics. Listen to the full transcript.
More from Cohance Lifescien…
All earning calls
Investor presentations from Cohance Lifescien…
All investor presentations